Come up with a name for your new list and we'll add to it:
ONL Therapeutics raised a round of funding on November 12, 2014. Investors include
National Eye Institute.
ONL Therapeutics is a biopharmaceutical company dedicated to protecting vision through the protection of photoreceptors. The current market for retinal drugs is greater than $7 billion and rapidly gro…